Gene/SNP

Geno/All

n cases

n controls

P

OR (95%CI)

BANK1

         

RS17266594

CC

5

13

0.4

 
 

CT

30

71

0.05

 
 

TT

55

70

0.0182

1.89 (1.11-3.2)

 

C

40

97

0.028

 
 

T

140

211

0.028

1.61 (1.05-2.46)

RS3733197

AA

2

11

0.084

 
 

AG

31

74

0.0172

0.52 (0.3-0.89)

 

GG

59

65

0.00168

2.34 (1.37-3.99)

 

A

35

96

0.00181

 
 

G

149

204

0.00181

2 (1.29-3.11)

CD3Z

         

RS1799704

AA

54

91

0.67

 
 

AC

27

63

0.13

 
 

CC

9

5

0.0241

3.42 (1.11-10.55)

 

A

135

245

0.6

 
 

C

45

73

0.6

 

RS2143302

CC

29

30

0.0142

2.10 (1.16-3.81)

 

CT

34

81

0.0588

 
 

TT

25

47

0.82

 
 

C

92

141

0.1

 
 

T

84

175

0.1

 

RS704848

CC

41

48

0.02

1.89 (1.1-3.25)

 

CG

29

80

0.0034

0.44 (0.26-0.76)

 

GG

18

24

0.36

 
 

C

111

176

0.26

 
 

G

65

128

0.26

 

RS858545

AA

22

19

0.0137

2.32 (1.18-4.56)

 

AC

34

78

0.06

 
 

CC

35

60

0.97

 
 

A

78

116

0.19

 
 

C

104

198

0.19

 

IL2

     

0.97

 

RS11575812

AA

59

74

0.006

2.11 (1.23-3.61)

 

AG

22

68

0.0064

0.42 (0.24-0.74)

 

GG

9

14

0.79

 
 

A

140

216

0.041

1.56 (1.02-2.38)

 

G

40

96

0.041

 

IL2RA

         

RS4147359

AA

14

13

0.06

 
 

AG

36

59

0.54

 
 

GG

35

82

0.07

 
 

A

64

85

0.023

1.58 (1.06-2.36)

 

G

106

223

0.023

 

IL2RB

         

RS743776

CC

9

5

0.029

3.29 (1.07-10.15)

 

CT

31

64

0.26

 
 

TT

51

86

0.93

 
 

C

49

74

0.45

 
 

T

133

236

0.45

 

IL2RB

         

RS84460

AA

14

10

0.0127

2.88 (1.22-6.82)

 

AG

26

72

0.011

0.49 (0.28-0.86)

 

GG

43

70

0.4

 
 

A

54

92

0.6

 
 

G

112

212

0.6

 

IRF5

         

RS10954213

AA

40

43

0.0098

2.06 (1.19-3.59)

 

AG

32

76

0.025

0.54 (0.31-0.93)

 

GG

14

26

0.75

 
 

A

112

162

0.05

 
 

G

60

128

0.05

 

RS2004640

GG

16

36

0.357

 
 

GT

37

78

0.214

 
 

TT

35

41

0.0313

1.84 (1.05-3.20)

 

G

69

150

0.05

 
 

T

107

160

0.05

 

RS2070197

CC

7

2

0.0049

7.3 (1.48-36.05)

 

CT

22

27

0.084

 
 

TT

48

119

0.0012

0.4 (0.22-0.75)

 

C

36

31

0.000264

2.61 (1.54-4.42)

 

T

118

265

0.000264

0.38 (0.23-0.65)

JAK1

         

RS310201

AA

47

78

0.66

 
 

AG

30

71

0.074

 
 

GG

13

9

1.99 x 10-2

2.80 (1.14-6.83)

 

A

124

227

0.49

 
 

G

56

89

0.49

 

RS7528403

GG

66

115

0.86

 
 

GT

17

41

0.21

 
 

TT

7

3

0.023

4.39 (1.1-17.41)

 

G

149

271

0.47

 
 

T

31

47

0.47

 

PTPN6

         

RS759052

CC

52

102

0.4

 
 

CT

27

51

0.79

 
 

TT

9

5

0.022

3.5 (1.13-10.75)

 

C

131

255

0.1

 
 

T

45

61

0.1

 

STAT4

         

RS7574865

GG

46

109

0.045

0.57 (0.32-0.99)

 

GT

28

44

0.312

 
 

TT

7

3

0.0147

4.8 (1.21-19.19)

 

G

120

262

0.0097

0.55 (0.34-0.87)

 

T

42

50

0.0097

1.83 (1.15-2.92)

TNFA

         

RS1800629

AA

9

6

0.0633

 
 

AG

34

36

0.0239

1.9 (1.08-3.35)

 

GG

50

113

0.0021

0.43 (0.25-0.74)

 

A

52

48

0.0008

2.12 (1.36-3.3)

 

G

134

262

0.0008

0.62 (0.42-0.93)

OR: Odds Ratio; CI: 95% Confidence Interval; Geno: Genotype; All: Allele
Table 2: Allelic and genotypic association results for associated SNPs in Tunisian SLE patients and healthy control.